Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Explore the best Visa credit card with rewards and no annual fee. Enjoy effortless earning on every transaction you make.
9,364 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
AI stocks have pulled back, but the fundamental machine beneath the hype is still growing. Learn why forget sell-off:...
Berkshire Hathaway reduced its cash hoard to $373.3 billion by year-end 2025, a 2.1% drop from September, as Greg Abe...
Mara Holdings and Riot Platforms fell Friday as higher energy costs collide with investors' questions about AI-driven...
First Trust AIRR, a small-cap industrial-focused ETF, has surged in 2026 and boasts a five-year performance well ahea...
Ownli extends its commission-free home listing platform to 43 states as of March 1, 2026, showcasing a data-driven al...
As markets wobble in early 2026, investors are increasingly pursuing a hybrid approach that blends bonds and dividend...
U.S. Customs announced a 45-day, no-lawsuits refund program for tariffs, aiming to speed refunds to importers and red...
A prominent fund has taken a sizable stake in Kirby Corporation, with eyes on a bold earnings target of $6.33 per sha...
Chip Wilson, founder of Lululemon, remains a disruptive voice as he pushes for board changes while the company prepar...
A cliff-like Medicare IRMAA rule makes a tiny annual income step cost retirees hundreds more each month. This report ...
Bitcoin, XRP, Ethereum, and Solana have all declined 6-8% over the past week, dragging the crypto market lower amid E...